These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4854978)

  • 1. The occurrence and significance of fibrin-fibrinogen degradation products (FDP) in acute infections.
    Skånsberg P; Cronberg S; Nilsson IM
    Scand J Infect Dis; 1974; 6(2):197-203. PubMed ID: 4854978
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of blood platelet counts, coagulation factors and serum fibrin/fibrinogen degradation products (FDP) in acute infections.
    Skånsberg P; Berg B
    Scand J Infect Dis; 1978; 10(1):61-5. PubMed ID: 635477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods.
    Satterwhite TK; Hawiger J; Burklow SL; Koenig MG
    J Infect Dis; 1973 Apr; 127(4):437-41. PubMed ID: 4694546
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of fibrinogen-fibrin degradation products by counterelectrophoresis.
    Brody JI
    J Clin Pathol; 1972 Sep; 25(9):754-6. PubMed ID: 5086217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
    Hillenbrand P; Parbhoo SP; Jedrychowski A; Sherlock S
    Scand J Gastroenterol Suppl; 1973; 19():133-4. PubMed ID: 4515635
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical utility of fibrin-related biomarkers in sepsis.
    Toh JM; Ken-Dror G; Downey C; Abrams ST
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):839-43. PubMed ID: 24030119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation activation and hyperviscosity in infection.
    Richardson SG; Matthews KB; Cruickshank JK; Geddes AM; Stuart J
    Br J Haematol; 1979 Jul; 42(3):469-80. PubMed ID: 476000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 10. Virus infection and blood coagulation.
    Linder M; Müller-Berghaus G; Lasch HG; Gagel C
    Thromb Diath Haemorrh; 1970 Feb; 23(1):1-11. PubMed ID: 5420432
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute Mycoplasma pulmonis infection associated with coagulopathy in C3H/HeN mice.
    Faulkner CB; Davidson MK; Davis JK; Schoeb TR; Simecka JW; Lindsey JR
    Lab Anim Sci; 1995 Aug; 45(4):368-72. PubMed ID: 7474874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of hemostatic mechanisms in bacterial infectious diseases.
    Tapper H; Herwald H
    Blood; 2000 Oct; 96(7):2329-37. PubMed ID: 11001879
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiological response of the blood coagulation system in acute glomerulonephritis.
    Alkjaersig NK; Fletcher AP; Lewis ML; Cole BR; Ingelfinger JR; Robson AM
    Kidney Int; 1976 Oct; 10(4):319-28. PubMed ID: 994377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
    Hillenbrand P; Parbhoo SP; Jedrychowski A; Sherlock S
    Gut; 1974 Feb; 15(2):83-8. PubMed ID: 4820641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
    Woodburn KR; Lowe GD; Rumley A; Love J; Pollock JG
    Int Angiol; 1995 Sep; 14(3):219-25. PubMed ID: 8919237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interactions of blood platelets and erythrocytes with fibrinogen and fibrin].
    Niewiarowski S; Stewart GG
    Pol Arch Med Wewn; 1978 Jan; 59(1):67-78. PubMed ID: 652583
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.